VetSheet

COP 항암화학요법 프로토콜

COP Chemotherapy Protocol

Cyclophosphamide, Vincristine, Prednisolone

항종양제 - 복합 항암화학요법POIV개

다른 이름: COP Protocol · High-dose COP · Cyclophosphamide, Oncovin, Prednisone · CVP protocol

VetSheet 수의사 팀 검수업데이트 2026년 4월 5일근거 기반 수의학 참고자료

2 mg/kg (week 1), 1.5 mg/kg (week 2), 1 mg/kg (week 3), 1 mg/kg thereafterPO· q24h (weeks 1-3), then q48h· First 6 months
— 🐕

용량은 수의사 전문가를 위한 임상 참고자료입니다. 반드시 최신 약물 정보 및 개별 환자에 따라 확인하시기 바랍니다.

동물 종별 용량

🌎 NA — North America🌍 EU — Europe

개

적응증용량경로빈도기간지역
COP Protocol - Induction (Cyclophosphamide)250 mg/m2POq21dFirst 6 months🌍 EU
COP Protocol - Induction (Vincristine)0.70 mg/m2IVq7d for 4 weeks, then q21dFirst 6 months🌍 EU
COP Protocol - Induction (Prednisolone)2 mg/kg (week 1), 1.5 mg/kg (week 2), 1 mg/kg (week 3), 1 mg/kg thereafterPOq24h (weeks 1-3), then q48hFirst 6 months🌍 EU
COP Protocol - Adjunct (Furosemide)1 mg/kgPOq12hFor 48h (4 doses) concurrent with cyclophosphamide🌍 EU
COP Protocol - Maintenance after 6 months (Cyclophosphamide)250 mg/m2POq28dMonths 6 to 12🌍 EU
COP Protocol - Maintenance after 6 months (Vincristine)0.70 mg/m2IVq28dMonths 6 to 12🌍 EU
COP Protocol - Maintenance after 6 months (Prednisolone)1 mg/kgPOq48hMonths 6 to 12🌍 EU
Alternative to Cyclophosphamide (Chlorambucil)20 mg/m2POAs directed replacing cyclophosphamideOngoing🌍 EU
  • COP Protocol - Induction (Cyclophosphamide): Administer with Furosemide to prevent haemorrhagic cystitis.
  • COP Protocol - Induction (Vincristine): On q21d schedule, give on the same day as cyclophosphamide.
  • COP Protocol - Induction (Prednisolone): Tapering dose schedule.
  • COP Protocol - Adjunct (Furosemide): Administered to promote diuresis and reduce risk of haemorrhagic cystitis.
  • COP Protocol - Maintenance after 6 months (Cyclophosphamide): Stop protocol after 12 months and monitor for relapse.
  • COP Protocol - Maintenance after 6 months (Vincristine): Administer with cyclophosphamide.
  • COP Protocol - Maintenance after 6 months (Prednisolone): Stop protocol after 12 months and monitor for relapse.
  • Alternative to Cyclophosphamide (Chlorambucil): Use if haemorrhagic cystitis develops or if blood is noted on urine dipstick and culture is negative.

용량은 수의사 전문가를 위한 임상 참고자료입니다. 반드시 최신 약물 정보 및 개별 환자에 따라 확인하시기 바랍니다.

진료 중이신가요? VetSheet의 AI가 약물, 용량, 투여 기간을 구조화된 진료 기록에 바로 기입합니다.VetSheet 작동 방식 보기

개요

​COP 프로토콜​(시클로포스파미드, 빈크리스틴, 프레드니솔론)은 주로 림프종 치료를 위해 수의 종양학에서 흔히 사용되는 복합 세포독성 화학요법입니다.

​임상 경고:​ 빈크리스틴은 강력한 발포성 약물입니다. 혈관 외 유출 시 심각한 조직 괴사를 유발합니다.

​임상 팁:​ 대부분의 종양 전문의는 CHOP 프로토콜을 선호하지만, 고용량 COP는 일반 진료 환경에서도 매우 유용하고 비교적 적용하기 쉬운 프로토콜입니다.

작용 기전

The COP protocol utilizes three distinct mechanisms to target neoplastic cells:

  • Cyclophosphamide: An alkylating agent that cross-links DNA strands → prevents DNA replication and transcription → induces cell death.
  • Vincristine: Binds to tubulin → inhibits microtubule formation and mitotic spindle assembly → arrests cell division in metaphase.
  • Prednisolone: A glucocorticoid that binds to specific intracellular receptors → alters gene expression → induces apoptosis in neoplastic lymphocytes.

안전성·주의사항

금기사항

  • Severe neutropenia (< 2 x 10^9/L)
  • Pre-existing haemorrhagic cystitis
  • Known MDR1 mutation (requires extreme caution/dose adjustment for vincristine)

부작용

  • Myelosuppression (neutropenia)
  • Haemorrhagic cystitis (cyclophosphamide)
  • Gastrointestinal toxicity (vomiting, diarrhoea, anorexia)
  • Tissue necrosis if extravasated (vincristine)

주의

​Vesicant Warning:​ Vincristine is a vesicant. IV catheters must be placed in all cases, and ONLY catheters placed by a clean 'first-stick' should be used.

​Myelosuppression:​ Discontinue cyclophosphamide if neutrophil count decreases to < 2 x 10^9/L. Check weekly and do not resume until > 3 x 10^9/L. If neutropenia recurs, decrease dose by 10-25%.

​MDR1 Mutation:​ Certain breeds (generally Collie type) are very sensitive to vincristine due to the MDR1 mutation; commercial testing is highly recommended prior to treatment.

​Clinical Pearl:​ GI protectants (e.g., Omeprazole 1 mg/kg q12-24h or Ranitidine with sucralfate) are recommended for the first 21 days of the protocol.

약물 상호작용

CimetidineMajor

Inhibits hepatic cytochrome P450 enzyme pathway, potentially altering the metabolism and increasing toxicity of chemotherapeutics.

모니터링

  • Haematology (prior to each vincristine treatment)
  • Biochemistry (prior to first treatment, then minimum every 6 months)
  • Free-catch urine dipstick (prior to each cyclophosphamide administration to check for blood)
  • Urine culture (if blood is noted on dipstick)

약동학

반감기

고양이Variable depending on specific drug개Variable depending on specific drug

흡수

Cyclophosphamide and Prednisolone are well absorbed orally. Vincristine must be given IV.

분포

Vincristine binds extensively to tissues. Cyclophosphamide is widely distributed.

대사

Cyclophosphamide requires hepatic activation (CYP450) to active alkylating metabolites. Vincristine is metabolized by the liver.

배설

Cyclophosphamide metabolites are excreted in urine (causing local toxicity). Vincristine is primarily excreted in feces via bile.

과다투여

​Severe toxicity:​ Overdose of these chemotherapeutics can lead to fatal myelosuppression, severe gastrointestinal sloughing, sepsis, and death. Extravasation of vincristine causes severe, progressive tissue necrosis requiring immediate management (e.g., hyaluronidase, warm compresses).

제품

제형

  • Oral tablets (Cyclophosphamide, Prednisolone, Chlorambucil, Furosemide)
  • Intravenous injection (Vincristine)

동물용의약품

  • Prednisolone tablets (various strengths)
  • Furosemide tablets (various strengths)

인용의약품

  • Cyclophosphamide tablets
  • Vincristine sulfate injection
  • Chlorambucil tablets

규제 현황

European Union✓ 승인됨처방전의약품EMA
🐕 Dogs🐈 Cats

Protocol utilizes a mix of veterinary-approved (prednisolone, furosemide) and human-approved (cyclophosphamide, vincristine) drugs under the cascade.

United Kingdom✓ 승인됨처방전의약품VMD
🐕 Dogs🐈 Cats

Administered under the prescribing cascade.

규제 데이터 없음: 🇺🇸 US · 🇭🇰 HK · 🇹🇼 TW · 🇯🇵 JP · 🇰🇷 KR · 🇦🇺 AU

보관·안정성

Store oral chemotherapeutics in their original, clearly labeled containers away from food and children. Vincristine injection requires refrigeration and protection from light. Follow strict hazardous drug handling protocols.

보호자 정보

반려동물이 COP라는 복합 항암화학요법을 받고 있습니다.

  • ​안전한 취급:​ 항암제는 반려동물의 소변과 대변으로 배출됩니다. 치료 후 최소 48시간 동안은 배설물을 처리하거나 청소할 때 반드시 일회용 장갑을 착용하십시오. 이후 손을 깨끗이 씻으십시오.
  • ​투약 방법:​ 항암제 알약을 절대 부수거나 쪼개지 마십시오.
  • ​관찰 사항:​ 감염 징후(기력 저하, 발열), 위장관 이상(구토, 설사, 식욕 부진) 또는 ​혈뇨​가 있는지 주의 깊게 관찰하십시오.
  • 혈뇨가 발견되면 즉시 시클로포스파미드 투여를 중단하고 수의사에게 연락하십시오. 이는 방광 자극(출혈성 방광염)을 의미할 수 있습니다.

VetSheet 의약품 참고자료는 수의사 전문가의 임상 의사결정 지원을 위한 것이며, 전문적 판단이나 제조사의 최신 약물 정보를 대체할 수 없습니다.